Delmax Pharmaceuticals Private Limited
About Delmax Pharmaceuticals Private Limited
Data last updated:
Delmax Pharmaceuticals Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the chemical distribution and retail segment of the chemicals and materials sector. It was incorporated on 17 June 2019 and has been in existence for over 7 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24100MH2019PTC326834. Its GSTIN is 27AAHCD2956L1Z8 (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Dattatray Janardhan Pannabhatti and Bhagyashri Sachin Daskhedkar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Aurangabad, Maharashtra.
As per the financials filed for FY 2024, the company reported a revenue of ₹39.68 Lakh, a decline of 5% compared to the previous year. For the same year it recorded a net profit of ₹1.36 Lakh (net margin 3.4%) and EBITDA of ₹2.71 Lakh (EBITDA margin 6.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressShop No As – 05 Udyog, Indrakamal A Type Gut No. 70 Beed By Pass Road, Aurangabad, Maharashtra, India – 431001
- IndustryChemicals and Materials, Chemical Distribution & Retail
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Delmax Pharmaceuticals Private Limited
The main business activity of Delmax Pharmaceuticals is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Delmax Pharmaceuticals Private Limited FY 2025 filings available
Delmax Pharmaceuticals Private Limited reported revenue of ₹39.68 Lakh (down 5% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Delmax Pharmaceuticals Private Limited
Revenue fell 5% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 29%. EBITDA rose 71% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Delmax Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.71 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.36 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Delmax Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.4% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Delmax Pharmaceuticals are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axonwave Pharmaceuticals Private Limited | ₹39.76 Lakh (FY 2025) | •••• | •••• | -7.0% | •••• | Uttamnagar, Delhi, India |
| Altona (Exim) Pvt.Ltd. | ₹39.76 Lakh (FY 2025) | •••• | •••• | -47.0% | •••• | Kolkata, West Bengal, India |
| Shree Malani Chemicals Private Limited | ₹39.72 Lakh (FY 2025) | •••• | •••• | -61.0% | •••• | Secunderabad, Telangana, India |
| Coris Chemicals and Pharmaceuticals Private Limited | ₹39.7 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Surat, Gujarat, India |
| Nihit Pharmaceuticals Private Limited | ₹39.68 Lakh (FY 2021) | •••• | •••• | 560.0% | •••• | Pune, Maharashtra, India |
| Delmax Pharmaceuticals Private Limited this company | ₹39.68 Lakh (FY 2024) | •••• | •••• | -5.0% | •••• | Aurangabad, Maharashtra, India |
| Earl Pharmaceuticals Private Limited | ₹39.67 Lakh (FY 2025) | •••• | •••• | 32.0% | •••• | Bareily, Uttar Pradesh, India |
| Chargewave Energykem Private Limited | ₹39.66 Lakh (FY 2025) | •••• | •••• | -10.0% | •••• | Secunderabad, Telangana, India |
| Pharmella Pharmaceuticals Private Limited | ₹39.64 Lakh (FY 2025) | •••• | •••• | 13.0% | •••• | Eluru, Andhra Pradesh, India |
| Admiris Pharmaceuticals Private Limited | ₹39.6 Lakh (FY 2025) | •••• | •••• | 80.0% | •••• | Dhubri, Assam, India |
| Bhashaja Pharmaceuticals Private Limited | ₹39.57 Lakh (FY 2024) | •••• | •••• | 0.0% | •••• | Kolkata, West Bengal, India |
Peers are the five companies nearest above and the five nearest below Delmax Pharmaceuticals by revenue in the Chemicals industry (Chemical Retail and Distribution, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals Private Limited is audited by S V GOSAVI & ASSOCIATES for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| S V GOSAVI & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Dattatray Janardhan Pannabhatti | Director | 17 Jun 2019 | 7 Years 3 Months | Current |
| Bhagyashri Sachin Daskhedkar | Director | 26 Oct 2020 | 5 Years 11 Months | Current |
Ownership and Shareholding of Delmax Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Delmax Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Delmax Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals Private Limited has 4 board changes on record since 2019: 2 appointments and 2 cessations. The latest: Bhagyashri Sachin Daskhedkar ceased to be Additional Director on 31 Dec 2020.
Credit Ratings, Litigation & Regulatory Alerts for Delmax Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Delmax Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Delmax Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAHCD2956L1Z8 | Maharashtra | Active | 29 Aug 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Delmax Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delmax Pharmaceuticals Private Limited
Delmax Pharmaceuticals is an active private limited company based in Aurangabad, Maharashtra, India. The company works in chemical distribution and retail, within the chemicals and materials industry. It was incorporated on 17 June 2019 (7+ years old) and is registered under CIN U24100MH2019PTC326834.
Delmax Pharmaceuticals reported revenue of ₹39.68 Lakh for FY 2024 (down 5% YoY).
Delmax Pharmaceuticals has 2 current directors:
- Dattatray Janardhan Pannabhatti - Director
- Bhagyashri Sachin Daskhedkar - Director
Delmax Pharmaceuticals reported a net profit of ₹1.36 Lakh (net margin 3.4%) and EBITDA of ₹2.71 Lakh (EBITDA margin 6.8%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Delmax Pharmaceuticals is 29% over three years. In the latest year (FY 2024) revenue fell 5%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Delmax Pharmaceuticals is 27AAHCD2956L1Z8, registered in Maharashtra.
The CIN (Corporate Identification Number) of Delmax Pharmaceuticals is U24100MH2019PTC326834. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delmax Pharmaceuticals was incorporated on 17 June 2019, making it 7+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Delmax Pharmaceuticals by revenue are Axonwave Pharmaceuticals Private Limited, Altona (Exim) Pvt.Ltd, Shree Malani Chemicals Private Limited, Coris Chemicals and Pharmaceuticals Private Limited, Nihit Pharmaceuticals Private Limited and 5 more, all in the Chemicals industry (Chemical Retail and Distribution, Pharmaceuticals).
Bhagyashri Sachin Daskhedkar ceased to be Additional Director on 31 Dec 2020. Bhagyashri Sachin Daskhedkar was appointed as Director on 26 Oct 2020. Renuka Vijay Giri ceased to be Director on 26 Oct 2020. Delmax Pharmaceuticals has 4 board changes on record in total.
The registered office of Delmax Pharmaceuticals is at Shop No As – 05 Udyog, Indrakamal A Type Gut No. 70 Beed By Pass Road, Aurangabad, Maharashtra, India – 431001.